Literature DB >> 11259275

X-linked inhibitor of apoptosis protein expression and the regulation of apoptosis during human placental development.

A Gruslin1, Q Qiu, B K Tsang.   

Abstract

In this study, we have examined the expression and potential role of X-linked inhibitor of apoptosis protein (XIAP), Fas, and Fas ligand (FasL) in the regulation of apoptosis throughout placental development. Protein expression was determined by Western blot analysis and immunohistochemistry, whereas apoptotic cell death was assessed by DNA fragmentation analysis and TUNEL. The XIAP was present in trophoblast throughout placental development, but its content significantly decreased during late pregnancy, when apoptosis was maximal. The FasL content was low during early placental development but increased coincidentally to the decrease in XIAP during the third trimester. Our data also suggest that placental apoptosis is the culmination of the relative expression of these cell-death and -survival proteins, a phenomenon that is cell type-specific and dependent on cytodifferentiation and the stage of placental development. Moreover, the induction of syncytiotrophoblast apoptosis may involve the concomitant up-regulation of FasL for Fas activation and the removal of downstream inhibition of the apoptotic cascade by XIAP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259275     DOI: 10.1095/biolreprod64.4.1264

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  9 in total

1.  Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas.

Authors:  Hakhyun Ka; Joan S Hunt
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

2.  AKT controls human first trimester trophoblast cell sensitivity to FAS-mediated apoptosis by regulating XIAP expression.

Authors:  Shawn L Straszewski-Chavez; Vikki M Abrahams; Paula B Aldo; Roberto Romero; Gil Mor
Journal:  Biol Reprod       Date:  2009-09-02       Impact factor: 4.285

3.  Increased placental XIAP and caspase 3 is associated with increased placental apoptosis in a baboon model of maternal nutrient reduction.

Authors:  Juan A Arroyo; Cun Li; Natalia Schlabritz-Loutsevitch; Tom McDonald; Peter Nathanielsz; Henry L Galan
Journal:  Am J Obstet Gynecol       Date:  2010-10       Impact factor: 8.661

4.  Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.

Authors:  Jean-Jacques Candelier; Lucien Frappart; Tarik Yadaden; Henriette Poaty; Jean-Yves Picard; Sophie Prévot; Philippe Coullin
Journal:  Pathol Oncol Res       Date:  2012-10-13       Impact factor: 3.201

5.  Decreased placental X-linked inhibitor of apoptosis protein in an ovine model of intrauterine growth restriction.

Authors:  Juan A Arroyo; Russell V Anthony; Henry L Galan
Journal:  Am J Obstet Gynecol       Date:  2008-03-04       Impact factor: 8.661

6.  Expression and prognostic significance of Livin in the progression of bladder cancer.

Authors:  Zhaohui Zhu; Yanbo Wang; Xiaobo Ding; Fuqing Zeng; Kai Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-02

7.  Analysis of inhibitor of apoptosis protein family expression during mammary gland development.

Authors:  Thomas W Owens; Fiona M Foster; Jolanta Tanianis-Hughes; Julia Y Cheung; Lisa Brackenbury; Charles H Streuli
Journal:  BMC Dev Biol       Date:  2010-06-28       Impact factor: 1.978

8.  Inhibitors of apoptosis: expression and regulation in the endometrium during the estrous cycle and at the maternal-conceptus interface during pregnancy in pigs.

Authors:  Inkyu Yoo; Wonchul Jung; Soohyung Lee; Yugyeong Cheon; Hakhyun Ka
Journal:  Anim Biosci       Date:  2021-09-15

9.  X-linked inhibitor of apoptosis protein negatively regulates neuronal differentiation through interaction with cRAF and Trk.

Authors:  Rut Fadó; Rana S Moubarak; Alfredo J Miñano-Molina; Bruna Barneda-Zahonero; Jorge Valero; Carlos A Saura; Julio Moran; Joan X Comella; José Rodríguez-Álvarez
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.